170 related articles for article (PubMed ID: 33240029)
1. Effects of paprika carotenoid supplementation on bone turnover in postmenopausal women: a randomized, double-blind, placebo-controlled, parallel-group comparison study.
Umigai N; Kozai Y; Saito T; Takara T
Food Nutr Res; 2020; 64():. PubMed ID: 33240029
[TBL] [Abstract][Full Text] [Related]
2. Safety Evaluation and Plasma Carotenoid Accumulation in Healthy Adult Subjects after 12 Weeks of Paprika Oleoresin Supplementation.
Umigai N; Murakami K; Shimizu R; Takeda R; Azuma T
J Oleo Sci; 2018 Feb; 67(2):225-234. PubMed ID: 29367485
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of carotenoids from paprika oleoresin into human chylomicrons.
Pérez-Gálvez A; Martin HD; Sies H; Stahl W
Br J Nutr; 2003 Jun; 89(6):787-93. PubMed ID: 12828795
[TBL] [Abstract][Full Text] [Related]
4. Biological Activities of Paprika Carotenoids, Capsanthin and Capsorubin.
Maeda H; Nishino A; Maoka T
Adv Exp Med Biol; 2021; 1261():285-293. PubMed ID: 33783751
[TBL] [Abstract][Full Text] [Related]
5. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
Nahas-Neto J; Cangussu LM; Orsatti CL; Bueloni-Dias FN; Poloni PF; Schmitt EB; Nahas EAP
Osteoporos Int; 2018 May; 29(5):1125-1133. PubMed ID: 29450585
[TBL] [Abstract][Full Text] [Related]
6. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
[TBL] [Abstract][Full Text] [Related]
7. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM
J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
[TBL] [Abstract][Full Text] [Related]
8. Effect of
Takimoto T; Hatanaka M; Hoshino T; Takara T; Tanaka K; Shimizu A; Morita H; Nakamura T
Biosci Microbiota Food Health; 2018; 37(4):87-96. PubMed ID: 30370192
[TBL] [Abstract][Full Text] [Related]
9. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
[TBL] [Abstract][Full Text] [Related]
10. Effects of Lemon Beverage Containing Citric Acid with Calcium Supplementation on Bone Metabolism and Mineral Density in Postmenopausal Women: Double-Blind 11-Month Intervention Study.
Ikeda H; Iida T; Hiramitsu M; Inoue T; Aoi S; Kanazashi M; Ishizaki F; Harada T
J Nutr Metab; 2021; 2021():8824753. PubMed ID: 33728061
[TBL] [Abstract][Full Text] [Related]
11. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
[TBL] [Abstract][Full Text] [Related]
12. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
13. Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled Trial.
Jafarnejad S; Djafarian K; Fazeli MR; Yekaninejad MS; Rostamian A; Keshavarz SA
J Am Coll Nutr; 2017; 36(7):497-506. PubMed ID: 28628374
[TBL] [Abstract][Full Text] [Related]
14. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
Rønn SH; Harsløf T; Oei L; Pedersen SB; Langdahl BL
Osteoporos Int; 2021 Jan; 32(1):185-191. PubMed ID: 33030563
[TBL] [Abstract][Full Text] [Related]
15. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
[TBL] [Abstract][Full Text] [Related]
16. Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial.
Hakala M; Kröger H; Valleala H; Hienonen-Kempas T; Lehtonen-Veromaa M; Heikkinen J; Tuomiranta T; Hannonen P; Paimela L;
Scand J Rheumatol; 2012 Aug; 41(4):260-6. PubMed ID: 22803768
[TBL] [Abstract][Full Text] [Related]
17. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A
Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
[TBL] [Abstract][Full Text] [Related]
18. Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial.
Jamal SA; Cummings SR; Hawker GA
J Bone Miner Res; 2004 Sep; 19(9):1512-7. PubMed ID: 15312252
[TBL] [Abstract][Full Text] [Related]
19. Carotenoids and Fatty Acids Obtained from Paprika
Kostrzewa D; Mazurek B; Kostrzewa M; Jóźwik E
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513310
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid.
Kasai H; Mori Y; Ose A; Shiraki M; Tanigawara Y
J Clin Pharmacol; 2021 May; 61(5):606-613. PubMed ID: 33135182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
